New pill for thyroid eye disease shows early promise
NCT ID NCT06467435
First seen Jan 04, 2026 · Last updated May 22, 2026 · Updated 20 times
Summary
This early study tested a drug called K9 in healthy volunteers and in people with thyroid eye disease (TED). The goal was to check safety and see if it helps with symptoms like dry eyes. Up to 10 patients took K9 twice daily for 24 weeks. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for THYROID EYE DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Kentucky
Lexington, Kentucky, 40506, United States
Conditions
Explore the condition pages connected to this study.